Thermo Fisher Scientific Inc.TMONYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank57
3Y CAGR-1.1%
5Y CAGR-3.9%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-1.1%/yr
vs +1.1%/yr prior
5Y CAGR
-3.9%/yr
Consistent
Acceleration
-2.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 25.73% | -6.5% |
| 2024 | 27.52% | +5.4% |
| 2023 | 26.12% | -1.8% |
| 2022 | 26.59% | -12.9% |
| 2021 | 30.52% | -2.7% |
| 2020 | 31.37% | +14.1% |
| 2019 | 27.50% | +8.1% |
| 2018 | 25.43% | +5.3% |
| 2017 | 24.16% | +3.9% |
| 2016 | 23.27% | - |